A parsimonious personalized dose-finding model via dimension reduction
通过降维构建简约的个性化剂量探索模型AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要研究个体化处理剂量规则及观察性研究中的价值函数学习。
通过降维构建简约的个性化剂量探索模型AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Summary Learning an individualized dose rule in personalized medicine is a challenging statistical problem. Existing methods often suffer from the curse of dimensionality, especially when the decision function is estimated nonparametrically. To tackle this problem, we propose a dimension reduction framework that effectively reduces the estimation to an optimization on a lower-dimensional subspace of the covariates. We exploit the fact that the individualized dose rule can be defined in a subspace spanned by a few linear combinations of the covariates to obtain a more parsimonious model. Owing to direct maximization of the value function, the proposed framework does not require the inverse probability of the propensity score under observational studies. This distinguishes our approach from the outcome-weighted learning framework, which also solves decision rules directly. Within the same framework, we further propose a pseudo-direct learning approach that focuses more on estimating the dimensionality-reduced subspace of the treatment outcome. Parameters in both approaches can be estimated efficiently using an orthogonality-constrained optimization algorithm on the Stiefel manifold. Under mild regularity assumptions, results on the asymptotic normality of the proposed estimators are established. We also derive the consistency and convergence rate of the value function under the estimated optimal dose rule. We evaluate the performance of the proposed approaches through extensive simulation studies and analysis of a pharmacogenetic dataset.